“Monoclonal Antibody Against CGRP (TEV-48125) for Preventive Treatment of Episodic Cluster Headache: A Phase II Randomized Clinical Trial Protocol”. Principles and Practice of Clinical Research 4, no. 1 (July 25, 2018): 14–20. Accessed May 7, 2024. https://journal.ppcr.org/index.php/ppcrjournal/article/view/53.